Allocating CBO’s Estimates of Federal Medicaid Spending Reductions and Enrollment Loss Across the States
The Congressional Budget Office’s (CBO) latest estimate shows that the One Big Beautiful Bill would…
Allocating CBO’s Estimates of Federal Medicaid Spending Reductions and Enrollment Loss Across the States
The Congressional Budget Office’s (CBO) latest estimate shows that the One Big Beautiful Bill would reduce federal Medicaid spending by $793 and that the Medicaid provisions would increase the number of uninsured people by 7.8 million. Previous CBO estimates show that 10.3 million fewer people would be enrolled in Medicaid in 2034. Building on prior…
Which Federal Agencies Make Medicare Work and How Were They Affected by Recent Changes Made by the Trump Administration?
This brief highlights some of the key federal agencies and offices that play a role in making Medicare work and, to the extent possible, describes the recent staffing and organizational changes made by the Trump administration that could affect the operations of Medicare in the future.
Factors That Increase Utilization Management Risk
That is the title of a new paper published in the American Journal of Managed Care (AJMC) with co-authors Jacob Fajnor, Shurui Zhang, and Donald Nichols. The abstract is below. Objectives: To (1) develop a metric that quantitatively measures the risk that utilization management (UM) policies pose to patients and (2) measure the relationship between…
Following Novo Nordisk, Eli Lilly Lands Partner for R&D of Longer-Acting Metabolic Meds
Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, permitting longer dosing intervals. Lilly plans to apply the technology to its metabolic medicines; the deal follows a similar move Novo Nordisk starting an alliance with Ascendis. The post Following Novo Nordisk, Eli Lilly…
How Can RWD Transform the Patient Journey?
[Sponsored] A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access. The post How Can RWD Transform the Patient Journey? appeared first on MedCity News.
Administration Releases Additional Details of Fiscal Year 2026 Budget Request
On May 30, 2025, the administration released additional details of its Fiscal Year 2026 budget request, including more specific information on funding for global health activities at the State Department, U.S. Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). The proposed budget includes significant…More
Federal Vaccine Advisory Committees: Roles and Current Issues
This brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the…
The Top 5 Home Care Franchise Opportunities in the U.S.
[Sponsored] The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high. The post The Top 5 Home Care Franchise Opportunities in the U.S. appeared first on MedCity News.
The Connected Patient Experience: 3 Tips to Empower Healthcare Delivery Through Innovation
Patients no longer want to rely upon only whatever snippets of information they get from their doctor at an annual or semiannual checkup. They’re looking for a fully connected patient experience. Healthcare organizations need to know what that looks like, how to build it, and how they fit into the full picture. The post The…
The National Security Stakes of Pharmaceutical Tariffs
Healthcare supplies have a direct correlation to the safety and national security of Americans as any disruption to availability jeopardizes the health of our nation. Americans cannot forego access to lifesaving medications. The post The National Security Stakes of Pharmaceutical Tariffs appeared first on MedCity News.
